2018 APEG共识指南:儿童和青少年应用双磷酸盐治疗

2018-03-05 澳大利亚儿科内分泌组 J Paediatr Child Health. 2018 Mar;54(3):223-233.

2018年3月,澳大利亚儿科内分泌组(APEG)发布了儿童和青少年应用双磷酸盐治疗共识指南,骨矿物工作组发布了儿童和青少年应用双磷酸盐治疗的共识指南。双磷酸盐是青年和儿童人群骨质脆弱的主要治疗药物,本文针药针对儿童和青少年应用双磷酸盐治疗的相关内容提出指导建议。

中文标题:

2018 APEG共识指南:儿童和青少年应用双磷酸盐治疗

英文标题:

Consensus guidelines on the use of bisphosphonate therapy in children and adolescents.

发布日期:

2018-03-05

简要介绍:

2018年3月,澳大利亚儿科内分泌组(APEG)发布了儿童和青少年应用双磷酸盐治疗共识指南,骨矿物工作组发布了儿童和青少年应用双磷酸盐治疗的共识指南。双磷酸盐是青年和儿童人群骨质脆弱的主要治疗药物,本文针药针对儿童和青少年应用双磷酸盐治疗的相关内容提出指导建议。

 

拓展指南:儿童相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 APEG共识指南:儿童和青少年应用双磷酸盐治疗)] GetToolGuiderByIdResponse(projectId=1, id=37fcd1c0015659e3, title=2018 APEG共识指南:儿童和青少年应用双磷酸盐治疗, enTitle=Consensus guidelines on the use of bisphosphonate therapy in children and adolescents., guiderFrom=J Paediatr Child Health. 2018 Mar;54(3):223-233., authorId=null, author=, summary=2018年3月,澳大利亚儿科内分泌组(APEG)发布了儿童和青少年应用双磷酸盐治疗共识指南,骨矿物工作组发布了儿童和青少年应用双磷酸盐治疗的共识指南。双磷酸盐是青年和儿童人群骨质脆弱的主要治疗药物,本文针药针对儿童和青少年应用双磷酸盐治疗的相关内容提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=1609, associationName=澳大利亚儿科内分泌组, associationIntro=, copyright=0, guiderPublishedTime=Mon Mar 05 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年3月,澳大利亚儿科内分泌组(APEG)发布了儿童和青少年应用双磷酸盐治疗共识指南,骨矿物工作组发布了儿童和青少年应用双磷酸盐治疗的共识指南。双磷酸盐是青年和儿童人群骨质脆弱的主要治疗药物,本文针药针对儿童和青少年应用双磷酸盐治疗的相关内容提出指导建议。 </P> <P> </P>拓展指南:<STRONG>与<FONT color=red>儿童</FONT>相关指南:</STRONG><BR> <UL> <LI><A title="2017 IDSA/SHEA临床实践指南:成人和儿童艰难梭菌感染的管理(更新版)" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=2753b1c0015582a7">2017 IDSA/SHEA临床实践指南:成人和儿童艰难梭菌感染的管理(更新版)</A> <LI><A title=中国儿童心律失常导管消融专家共识解读 target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=2c5a71c001555576">中国儿童心律失常导管消融专家共识解读</A> <LI><A title="2018 IRLSSG临床共识指南:铁剂治疗成人和儿童不宁腿综合征/Willis-Ekbom病" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=73c471c0015553ad">2018 IRLSSG临床共识指南:铁剂治疗成人和儿童不宁腿综合征/Willis-Ekbom病</A> <LI><A title="2018 NASPGHAN临床报告:儿童人群急性胰腺炎的管理" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=b7b591c001555009">2018 NASPGHAN临床报告:儿童人群急性胰腺炎的管理</A> <LI><A title="2018 循证共识指南:儿童外伤性颅脑损伤后交流和吞咽障碍的管理" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=67f121c0015515b5">2018 循证共识指南:儿童外伤性颅脑损伤后交流和吞咽障碍的管理</A> 更多信息请点击:<A target=_blank href="http://www.medsci.cn/guideline/list.do?q=%E5%84%BF%E7%AB%A5">有关儿童更多指南</A></LI></UL>, tagList=[TagDto(tagId=3306, tagName=双磷酸盐), TagDto(tagId=71432, tagName=骨骼脆弱)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6305, appHits=114, showAppHits=0, pcHits=4989, showPcHits=2028, likes=191, shares=2, comments=3, approvalStatus=1, publishedTime=Sat Mar 10 21:50:38 CST 2018, publishedTimeString=2018-03-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Mar 10 21:50:38 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 03:05:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 APEG共识指南:儿童和青少年应用双磷酸盐治疗)])
2018 APEG共识指南:儿童和青少年应用双磷酸盐治疗
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=296087, encodeId=916629608e8b, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Mar 14 07:37:02 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294961, encodeId=5eaf29496192, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Mar 10 22:49:09 CST 2018, time=2018-03-10, status=1, ipAttribution=)]
    2018-03-14 大爰

    学习了谢谢分享!!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=296087, encodeId=916629608e8b, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Mar 14 07:37:02 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=294961, encodeId=5eaf29496192, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Mar 10 22:49:09 CST 2018, time=2018-03-10, status=1, ipAttribution=)]
    2018-03-10 惠映实验室

    学习.谢谢分享.

    0